VanEck Associates’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-9,300
| Closed | -$4.96M | – | 854 |
|
|
2019
Q2 | $4.96M | Sell |
9,300
-5,809
| -38% | -$3.1M | 0.02% | 343 |
|
|
2019
Q1 | $7.62M | Buy |
15,109
+650
| +4% | +$328K | 0.04% | 259 |
|
|
2018
Q4 | $7.13M | Sell |
14,459
-389
| -3% | -$192K | 0.04% | 255 |
|
|
2018
Q3 | $13.6M | Buy |
14,848
+2,404
| +19% | +$2.2M | 0.07% | 217 |
|
|
2018
Q2 | $9.12M | Buy |
12,444
+972
| +8% | +$712K | 0.04% | 237 |
|
|
2018
Q1 | $18.3M | Buy |
+11,472
| New | +$18.3M | 0.09% | 182 |
|
|
2017
Q1 | – | Sell |
-110
| Closed | -$20K | – | 902 |
|
|
2016
Q4 | $20K | Buy |
110
+54
| +96% | +$9.82K | ﹤0.01% | 865 |
|
|
2016
Q3 | $14K | Sell |
56
-31
| -36% | -$7.75K | ﹤0.01% | 852 |
|
|
2016
Q2 | $19K | Buy |
87
+8
| +10% | +$1.75K | ﹤0.01% | 830 |
|
|
2016
Q1 | $16K | Buy |
+79
| New | +$16K | ﹤0.01% | 808 |
|